The Covishield vaccine developed by Serum Institute of India (SII) received Emergency Use Authorisation (EAU) after going through established safety and immunogenicity in a well-prescribed regulatory process
The vaccine is currently being used in the country. After that, the Serum Institute of India is likely to launch a new vaccine against the virus soon.
The chief of Serum Institute of India Adar Poonawalla on Saturday (January 30, 2021) announced that the company is looking forward to launch a second coronavirus vaccine, which if approved, could be India's third COVID-19 vaccine.
The SII has claimed that Novavax, a vaccine undergoing trials, has shown 'excellent efficacy results' against the novel coronavirus.
Taking to Twitter, Poonawalla said, "Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!"